Skip to main content
SWOG logo

User account menu

  • Log in

Main navigation

  • About
    • History & Impact
    • Mission & Values
    • Leadership
    • Support SWOG
    • Join SWOG
    • Policies & Procedures
    • Careers
    • Contact Us
  • The SWOG Network
    • How We Work
    • Our Staff
    • Our Advocates
    • Our Partners
  • News & Events
    • News
    • SWOG Meetings
    • For Press
  • Clinical Trials
    • Biospecimen Submission
    • Biospecimen Access
    • Data Requests
    • Clinical Trials Search
    • Clinical Research Resources
    • Frequently Asked Questions
    • Publications
    • Institutions
    • Quality Assurance & Audits
    • Serious Adverse Events
    • Training Resources
    • ORP (CRA) Workbench
    • Protocol Workbench
  • Workbenches
    • ORP (CRA) Workbench
    • Protocol Workbench
    • VA Workbench
  • For Patients
    • Patient & Advocate Voices
    • Trials Open to Patients
    • About SWOG Cancer Trials
    • Joining a Trial

Section navigation

  • Recent Updates
    • 12/1/2025
    • 11/15/2025
    • 11/1/2025
    • 10/15/2025
    • 10/1/2025
    • 9/15/2025
    • 9/1/2025
    • 8/15/2025
    • 8/1/2025
    • 7/15/2025
    • 7/1/2025
    • 6/15/2025
    • All Updates

Breadcrumb

  1. SWOG
  2. Member Resources
  3. Trial & Business Updates
  4. Cancer Care Delivery

Priority List Cancer Care Delivery

CTSU/EAQ221CD
Other
Improving Medication Adherence in Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP) SWOG Study Champion: Scott Ramsey, M.D., Ph.D. -
CTSU/EAQ222CD
Other
Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients SWOG Champion: Veena Shankaran, M.D.
S2417CD
III
A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance
S1703
III
Randomized trial comparing overall survival of patients monitored with serum tumor marker directed disease monitoring (STMDDM) versus usual care in patients with metastatic hormone receptor positive breast cancer
SWOG logo

Footer: Social Links

  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2025

Footer

  • Disclaimer